» Articles » PMID: 37468553

Differentiation Between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Using a Deep Learning Model

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jul 19
PMID 37468553
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are autoimmune inflammatory disorders of the central nervous system (CNS) with similar characteristics. The differential diagnosis between MS and NMOSD is critical for initiating early effective therapy. In this study, we developed a deep learning model to differentiate between multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) using brain magnetic resonance imaging (MRI) data. The model was based on a modified ResNet18 convolution neural network trained with 5-channel images created by selecting five 2D slices of 3D FLAIR images. The accuracy of the model was 76.1%, with a sensitivity of 77.3% and a specificity of 74.8%. Positive and negative predictive values were 76.9% and 78.6%, respectively, with an area under the curve of 0.85. Application of Grad-CAM to the model revealed that white matter lesions were the major classifier. This compact model may aid in the differential diagnosis of MS and NMOSD in clinical practice.

Citing Articles

Development of a Panel of Biomarkers for Differential Diagnosis of Multiple Sclerosis.

Ovchinnikova L, Dzhelad S, Simaniv T, Zakharova M, Lomakin Y, Gabibov A Dokl Biochem Biophys. 2024; 519(1):593-596.

PMID: 39528814 PMC: 11739224. DOI: 10.1134/S160767292460060X.

References
1.
Seok J, Cho W, Son D, Shin J, Cho E, Kim S . Association of subcortical structural shapes with fatigue in neuromyelitis optica spectrum disorder. Sci Rep. 2022; 12(1):1579. PMC: 8799731. DOI: 10.1038/s41598-022-05531-1. View

2.
Waters P, McKeon A, Leite M, Rajasekharan S, Lennon V, Villalobos A . Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012; 78(9):665-71. PMC: 3286228. DOI: 10.1212/WNL.0b013e318248dec1. View

3.
Patel U, Anwar A, Saleem S, Malik P, Rasul B, Patel K . Artificial intelligence as an emerging technology in the current care of neurological disorders. J Neurol. 2019; 268(5):1623-1642. DOI: 10.1007/s00415-019-09518-3. View

4.
Matthews L, Marasco R, Jenkinson M, Kuker W, Luppe S, Leite M . Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology. 2013; 80(14):1330-7. PMC: 3656462. DOI: 10.1212/WNL.0b013e3182887957. View

5.
Kim H, Lee Y, Kim Y, Lim Y, Lee J, Woo J . Deep Learning-Based Method to Differentiate Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis. Front Neurol. 2020; 11:599042. PMC: 7734316. DOI: 10.3389/fneur.2020.599042. View